James Anthony Cannon

All filings by James Anthony Cannon on record concern Alaunos Therapeutics, Inc. In total, 3 filings cover trades dated 31 December 2015.

None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.

The record was last updated on 5 January 2016 with a share grant in Alaunos Therapeutics, Inc. The median gap between a trade and its publication by SEC (Form 4) is 5 days. For comparison, the SEC allows two business days to file a Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.